[ANMCO/AICO/AIOM Consensus document: Clinical and management pathways in cardio-oncology]

Luigi Tarantini1, Michele Massimo Gulizia2, Andrea Di Lenarda3

  • 1S.C. Cardiologia, Ospedale San Martino, Azienda ULSS 1, Belluno.

Giornale Italiano Di Cardiologia (2006)
|March 14, 2017
PubMed

Insights

Cardio-oncology addresses heart damage from cancer treatments, a growing concern with increased cancer survival. This field guides oncologists and cardiologists in managing cancer care while minimizing cardiac risks.

Area of Science:

  • Oncology
  • Cardiology
  • Cardio-oncology

Background:

  • Cardiovascular diseases and cancer are leading causes of death in Italy, often coexisting in elderly patients.
  • Improved cancer survival leads to increased cardiovascular complications from cardiotoxic cancer therapies.
  • This necessitates a collaborative approach between cardiology and oncology.

Purpose of the Study:

  • To establish practical recommendations for managing cardiac toxicity in cancer patients.
  • To guide the multidisciplinary collaboration between cardiologists and oncologists.
  • To optimize cancer treatment while minimizing cardiac risks.

Main Methods:

  • Development of a consensus document based on multidisciplinary collaboration.
  • Providing practical recommendations for assessment, monitoring, and treatment.
  • Focus on protecting heart health throughout oncological disease stages.

Main Results:

  • Establishment of cardio-oncology as a clinical discipline.
  • Framework for managing and preventing cardiotoxicity.
  • Guidelines for integrated cancer and cardiac care.

Conclusions:

  • Cardio-oncology is essential for managing cancer patients at risk of cardiac complications.
  • Multidisciplinary collaboration is key to balancing cancer treatment efficacy and cardiac safety.
  • The consensus document provides a practical guide for clinicians.

Related Concept Videos

Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...